Corient Private Wealth’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $543K | Sell |
205,595
-22,073
| -10% | -$58.3K | ﹤0.01% | 1756 |
|
|
2025
Q1 | $685K | Buy |
227,668
+5,288
| +2% | +$15.9K | ﹤0.01% | 1447 |
|
|
2024
Q4 | $569K | Sell |
222,380
-224,080
| -50% | -$574K | ﹤0.01% | 1548 |
|
|
2024
Q3 | $1.66M | Buy |
446,460
+224,380
| +101% | +$835K | ﹤0.01% | 1157 |
|
|
2024
Q2 | $1.4M | Buy |
222,080
+550
| +0.2% | +$3.48K | ﹤0.01% | 1185 |
|
|
2024
Q1 | $1.19M | Sell |
221,530
-1,900
| -0.9% | -$10.2K | ﹤0.01% | 1249 |
|
|
2023
Q4 | $1.12M | Buy |
223,430
+49,729
| +29% | +$250K | ﹤0.01% | 1236 |
|
|
2023
Q3 | $294K | Buy |
173,701
+114,272
| +192% | +$193K | ﹤0.01% | 1750 |
|
|
2023
Q2 | $165K | Sell |
59,429
-53
| -0.1% | -$147 | ﹤0.01% | 1897 |
|
|
2023
Q1 | $108K | Buy |
59,482
+35,852
| +152% | +$65.3K | ﹤0.01% | 1860 |
|
|
2022
Q4 | $120K | Buy |
+23,630
| New | +$120K | ﹤0.01% | 1543 |
|